Package 68083-592-01

Brand: eribulin mesylate

Generic: eribulin mesylate
NDC Package

Package Facts

Identity

Package NDC 68083-592-01
Digits Only 6808359201
Product NDC 68083-592
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-04-05
Brand eribulin mesylate
Generic eribulin mesylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "5db5b24e-3893-4985-a658-731cb840eb76", "openfda": {"upc": ["0368083592011"], "unii": ["AV9U0660CW"], "rxcui": ["1045456"], "spl_set_id": ["f57835e2-4c53-4e93-b54b-7d7a5000ae3d"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68083-592-01", "marketing_start_date": "20240405"}], "brand_name": "eribulin mesylate", "product_id": "68083-592_5db5b24e-3893-4985-a658-731cb840eb76", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "68083-592", "generic_name": "eribulin mesylate", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "eribulin mesylate", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "ANDA218047", "marketing_category": "ANDA", "marketing_start_date": "20240405", "listing_expiration_date": "20261231"}